EPIGENOMIC MASTER REGULATORS THAT DEFINE IDH1/2 MUTANT GLIOMA TUMOR PROGRESSION

$602,000FY2018Department of the ArmyDOD

Henry Ford Health System, Detroit MI

Investigators

View source on USAspending →